Global Clinical Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety and Performance Measures

Medtronic plc (NYSE: MDT) today announced study results of its Micra® Transcatheter Pacing System (TPS), which demonstrated that the miniaturized pacemaker has met its initial safety and performance measures. In the largest report to date of a transcatheter pacing system, 100 percent of the first 140 patients who received the Micra TPS experienced a successful implant procedure, and mean electrical pacing measurements at all patient visits (one- and three--month follow up) were within expected ranges.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news